ALBAYATI , D. I. R.; ODAY HATEM, D. A. Effectiveness and Safety of Ocrelizumab in Primary Progressive Multiple Sclerosis among Iraqi Patients. World of Medicine : Journal of Biomedical Sciences, [S. l.], v. 2, n. 3, p. 86–91, 2025. Disponível em: https://wom.semanticjournals.org/index.php/biomed/article/view/322. Acesso em: 18 mar. 2025.